Systematic analysis of cancer-specific synthetic lethal interactions provides insight into personalized anticancer therapy.
FEBS J
; 290(6): 1531-1548, 2023 03.
Article
in En
| MEDLINE
| ID: mdl-36181326
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Genes, Lethal
/
Neoplasms
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
FEBS J
Year:
2023
Document type:
Article